153 related articles for article (PubMed ID: 31025569)
1. Riociguat, sildenafil and inhaled nitric oxide reduces pulmonary vascular resistance and improves right ventricular function in a porcine model of acute pulmonary embolism.
Schultz J; Andersen A; Gade IL; Kjaergaard B; Nielsen-Kudsk JE
Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):293-301. PubMed ID: 31025569
[TBL] [Abstract][Full Text] [Related]
2. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
[TBL] [Abstract][Full Text] [Related]
4. Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics.
Darocha S; Banaszkiewicz M; Pietrasik A; Piłka M; Florczyk M; Wieteska M; Dobosiewicz A; Szmit S; Torbicki A; Kurzyna M
Int J Cardiol; 2018 Oct; 269():283-288. PubMed ID: 30017517
[TBL] [Abstract][Full Text] [Related]
5. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).
Suntharalingam J; Hughes RJ; Goldsmith K; Doughty N; George P; Toshner M; Sheares KK; Pepke-Zaba J
Vascul Pharmacol; 2007 Jun; 46(6):449-55. PubMed ID: 17368113
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial.
Andersen A; Waziri F; Schultz JG; Holmboe S; Becker SW; Jensen T; Søndergaard HM; Dodt KK; May O; Mortensen UM; Kim WY; Mellemkjær S; Nielsen-Kudsk JE
BMC Pulm Med; 2021 Feb; 21(1):72. PubMed ID: 33639897
[TBL] [Abstract][Full Text] [Related]
7. Soluble guanylate cyclase stimulators in pulmonary hypertension.
Stasch JP; Evgenov OV
Handb Exp Pharmacol; 2013; 218():279-313. PubMed ID: 24092345
[TBL] [Abstract][Full Text] [Related]
8. Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular-Pulmonary Arterial Coupling.
Taran IN; Belevskaya AA; Saidova MA; Martynyuk TV; Chazova IE
Lung; 2018 Dec; 196(6):745-753. PubMed ID: 30182153
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study).
Marra AM; Halank M; Benjamin N; Bossone E; Cittadini A; Eichstaedt CA; Egenlauf B; Harutyunova S; Fischer C; Gall H; Ghofrani HA; Hoeper MM; Lange TJ; Olsson KM; Klose H; Grünig E
Respir Res; 2018 Dec; 19(1):258. PubMed ID: 30567595
[TBL] [Abstract][Full Text] [Related]
10. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
11. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism.
Dias-Junior CA; Montenegro MF; Florencio BC; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):374-9. PubMed ID: 18834358
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs.
Thelitz S; Oishi P; Sanchez LS; Bekker JM; Ovadia B; Johengen MJ; Black SM; Fineman JR
Pediatr Crit Care Med; 2004 May; 5(3):234-9. PubMed ID: 15115560
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin Increases Systemic and Lowers Pulmonary Arterial Pressure in Experimental Acute Pulmonary Embolism.
Schultz J; Andersen A; Lyhne MD; Arcanjo DDR; Kjaergaard B; Simonsen U; Nielsen-Kudsk JE
Crit Care Med; 2020 Apr; 48(4):e308-e315. PubMed ID: 32205621
[TBL] [Abstract][Full Text] [Related]
16. Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors.
Hoeper MM; Klinger JR; Benza RL; Simonneau G; Langleben D; Naeije R; Corris PA
Respir Med; 2017 Jan; 122 Suppl 1():S18-S22. PubMed ID: 27887774
[TBL] [Abstract][Full Text] [Related]
17. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.
Michelakis E; Tymchak W; Lien D; Webster L; Hashimoto K; Archer S
Circulation; 2002 May; 105(20):2398-403. PubMed ID: 12021227
[TBL] [Abstract][Full Text] [Related]
18. Impact of Preload on Right Ventricular Hemodynamics in Acute Pulmonary Embolism.
Mortensen CS; Kramer A; Schultz J; Lyhne MD; Nielsen-Kudsk JE; Andersen A
Crit Care Med; 2020 Dec; 48(12):e1306-e1312. PubMed ID: 33060507
[TBL] [Abstract][Full Text] [Related]
19. Effects of sildenafil on hypoxic pulmonary vascular function in dogs.
Fesler P; Pagnamenta A; Rondelet B; Kerbaul F; Naeije R
J Appl Physiol (1985); 2006 Oct; 101(4):1085-90. PubMed ID: 16778005
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator, Riociguat, and an Activator, Cinaciguat, During NO-Modulation in Healthy Pigs.
Næsheim T; How OJ; Myrmel T
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):75-87. PubMed ID: 32662299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
